CHOLERA remains rare in travelers, but risk rises with unsafe water, outbreak exposure, and delayed treatment.
Cholera In Travelers: Who Is Most at Risk?
Cholera is an intestinal infection caused by Vibrio cholerae, with illness ranging from asymptomatic or mild disease to severe secretory diarrhea, dehydration, and death within hours if untreated. For healthcare professionals assessing cholera in travelers, risk depends on several factors, including the level of transmission at the destination, the length of exposure in outbreak settings, and the traveler’s ability to follow food and water precautions. Risk also rises in those with limited access to medical care, especially where intravenous rehydration may not be readily available.
The review emphasizes that cholera can occur in people visiting friends or family, healthcare workers, and response workers in outbreak settings. Although severe cholera is uncommon in travelers, infected individuals can continue shedding V. cholerae into the environment, creating ongoing transmission risk.
Prevention Strategies for Cholera in Travelers
The main route of cholera transmission is fecal oral spread, making safe food and water practices central to prevention. Travelers to areas where cholera is present should drink boiled water, chlorine treated or iodine treated water, or bottled beverages. Foods should be thoroughly cooked, and travelers should peel their own fruit when possible. During outbreaks, avoiding unsafe food and water, street vendor products, raw foods, ice cream, and ice is especially important.
Frequent and thorough hand washing also remains a key preventive measure. The article notes that travelers may take longer trips and may not always have reliable access to safe food and water, which can increase vulnerability.
Vaccination And Clinical Relevance
Vaccination is presented as an important part of cholera control in travelers. In the United States, the only available cholera vaccine is Vaxchora, which is recommended for adults traveling to areas with active cholera transmission and is designed to prevent severe diarrhea caused by the most common type of cholera. The review also highlights oral inactivated cholera vaccines used more widely in outbreak responses in low-income settings.
For clinicians, the key message is practical: a definitive diagnosis is not required before treatment begins. Timely rehydration remains the priority in suspected cholera, while preventive counseling on transmission and vaccination can reduce both individual risk and broader spread.
Reference
Murugaiah C et al. Cholera for travellers. Eur J Clin Microbiol Infect Dis. 2026;doi:10.1007/s10096-026-05492-7.
Featured Image: leungchopan on Adobe Stock.
